The price of a drug infusion can vary significantly depending on the floor or building where it is administered, a situation created by Medicare’s payment system. This discrepancy is also seen in surgical costs, contributing to billions in healthcare expenses. Criticisms highlight that current healthcare interests exploit this government policy to generate millions of dollars. Marty Makary has written an op-ed discussing how this system is fostering monopolies within the healthcare industry and addressing bipartisan health concerns.